90674849
Apr 27, 2021
Pharmaceutical preparations for the treatment of inflammatory bowel disease, namely, Crohn's disease; Pharmaceutical preparations for the treatment of pulmonary disease, namely, pulmonary mycobacterium avium complex (MAC) disease; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of gastrointestinal diseases; Pharmaceutical preparations for the treatment of bacterial infections
Pharmaceuticals